Source: Annual Congress 2006 - Airway cell biology
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Tzouvelekis, E. Tsiambas, A. Karameris, A. Koutsopoulos, R. Triggidou, M. Froudarakis, P. Steiropoulos, M. Doris, S. Anevlavis, D. Bouros (Alexandroupolis, Athens, Heraklion, Greece). Morphometric study of telomerase activity in patients with idiopathic pulmonary fibrosis with the use of tissue microarrays. Eur Respir J 2006; 28: Suppl. 50, 4930

Member's Comments

No comment yet.

Related content which might interest you: Comparative proteome analysis of lung tissue from patients with idiopathic pulmonary fibrosis, non-specific interstitial pneumonia and human donor lungs Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology? Year: 2008 Morphometric study of hypoxia inducible factor-1α-vascular endothelial growth factor (HIF-1α-VEGF) axis in patients with idiopathic pulmonary fibrosis with the use of tissue microarrays Source: Eur Respir J 2006; 28: Suppl. 50, 338s Year: 2006 Differential expression of telomerase activity in patients with autoimmune pulmonary fibrosis in BALF Source: Annual Congress 2010 - Different patterns of diffuse parenchymal lung disease Year: 2010 The markers of inflammatory process activity and fybrogenesis activity in patients with idiopathic pulmonary fibrosis Source: Annual Congress 2012 - Diffuse parenchymal lung disease I Year: 2012 Textural analysis demonstrates heterogeneous [18F]-fluorodeoxyglucose uptake in radiologically normal lung in patients with idiopathic pulmonary fibrosis Source: Eur Respir J, 52 (5) 1801138; 10.1183/13993003.01138-2018 Year: 2018 Increased polysialylation in lung tissue of patients with idiopathic pulmonary fibrosis Source: Annual Congress 2011 - Cell biology of lung disease Year: 2011 The effect of emphysema in patients with idiopathic pulmonary fibrosis; evaluation using quantitative CT analysis Source: International Congress 2016 – IPF: from pathogenesis to treatment I Year: 2016 Procoagulant and antifibrynolitic activities strongly correlate with fibrosis and tissue turn-over markers in patients with active idiopathic pulmonary fibrosis and hypersensitivity pneumonitis Source: Annual Congress 2008 - Clinical aspects of interstitial lung disease Year: 2008 Analysis of the lung microbiota in healthy dogs and in canine idiopathic pulmonary fibrosis, a possible spontaneous model for human IPF. Source: International Congress 2018 – Pulmonary fibrosis: from models to patients Year: 2018 A comparative histological study of pulmonary vascular lesions in lungs of patients With idiopathic or heritable PAH Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment Year: 2013 Expression of apoptotic markers in patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2003; 22: Suppl. 45, 376s Year: 2003 Does the questionnaire “human activity profile” assess functional capacity in patients with idiopathic pulmonary fibrosis? Source: Virtual Congress 2021 – News in treatment and diagnosis of idiopathic interstitial pneumonia Year: 2021 Expression of hyaluronidase by interstitial myofibroblasts and epithelial cells is associated with fibrosis extension, clinical forms and pulmonary function stage in patients with systemic sclerosis Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease Year: 2010 Morphology of pulmonary tissue in patients with COPD Source: Eur Respir J 2003; 22: Suppl. 45, 456s Year: 2003 Autopsy findings in 42 consecutive patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2008; 32: 170-174 Year: 2008 Efficacy of pirfenidone in patients with idiopathic pulmonary fibrosis with more preserved lung function Source: Eur Respir J 2016; 48: 843-851 Year: 2016 Final analysis of RECAP, an open-label extension study of pirfenidone in patients with idiopathic pulmonary fibrosis (IPF) Source: International Congress 2016 – IPF treatment I Year: 2016 Angiogenic activity of sera from patients with various types of pulmonary fibrosis in relation to pulmonary functions Source: Annual Congress 2009 - Pathological remodelling in chronic lung disease: from epithelial-mesenchymal transition to cellular activation Year: 2009 Distinct gene expression profiles of cultured stromal cells from the patients with idiopathic pulmonary fibrosis and lung adenocarcinoma Source: International Congress 2015 – Translational studies in airway cell biology Year: 2015 Significance of histopathologic features suggesting connective tissue disease in idiopathic pulmonary fibrosis Source: International Congress 2015 – Connective tissue disorders Year: 2015